ラクオリア創薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/03/04 | 838 | 840 | 802 | 812 | -27 | -3.2% | 210,800 |
| 2022/03/03 | 859 | 865 | 839 | 839 | -12 | -1.4% | 99,400 |
| 2022/03/02 | 859 | 861 | 843 | 851 | -18 | -2.1% | 137,000 |
| 2022/03/01 | 883 | 883 | 869 | 869 | +9 | +1% | 119,700 |
| 2022/02/28 | 843 | 862 | 840 | 860 | +7 | +0.8% | 97,900 |
| 2022/02/25 | 842 | 855 | 834 | 853 | +31 | +3.8% | 174,400 |
| 2022/02/24 | 882 | 882 | 816 | 822 | -60 | -6.8% | 358,000 |
| 2022/02/22 | 908 | 915 | 882 | 882 | -26 | -2.9% | 189,800 |
| 2022/02/21 | 914 | 914 | 886 | 908 | -9 | -1% | 224,900 |
| 2022/02/18 | 906 | 918 | 900 | 917 | +1 | +0.1% | 160,500 |
| 2022/02/17 | 934 | 939 | 912 | 916 | -26 | -2.8% | 136,400 |
| 2022/02/16 | 947 | 958 | 927 | 942 | -1 | -0.1% | 145,200 |
| 2022/02/15 | 950 | 995 | 943 | 943 | -19 | -2% | 188,700 |
| 2022/02/14 | 963 | 970 | 931 | 962 | -21 | -2.1% | 167,900 |
| 2022/02/10 | 976 | 992 | 975 | 983 | +9 | +0.9% | 111,300 |
| 2022/02/09 | 968 | 979 | 954 | 974 | +14 | +1.5% | 70,000 |
| 2022/02/08 | 960 | 972 | 956 | 960 | +4 | +0.4% | 84,200 |
| 2022/02/07 | 973 | 980 | 954 | 956 | -15 | -1.5% | 78,000 |
| 2022/02/04 | 975 | 983 | 959 | 971 | -14 | -1.4% | 124,400 |
| 2022/02/03 | 980 | 997 | 969 | 985 | -2 | -0.2% | 158,100 |
| 2022/02/02 | 960 | 993 | 955 | 987 | +31 | +3.2% | 122,900 |
| 2022/02/01 | 960 | 970 | 934 | 956 | +5 | +0.5% | 128,800 |
| 2022/01/31 | 945 | 960 | 933 | 951 | +9 | +1% | 136,200 |
| 2022/01/28 | 928 | 949 | 921 | 942 | +15 | +1.6% | 141,700 |
| 2022/01/27 | 985 | 985 | 922 | 927 | -51 | -5.2% | 313,600 |
| 2022/01/26 | 979 | 999 | 970 | 978 | -6 | -0.6% | 141,400 |
| 2022/01/25 | 1,037 | 1,040 | 981 | 984 | -42 | -4.1% | 198,200 |
| 2022/01/24 | 1,025 | 1,032 | 1,007 | 1,026 | -19 | -1.8% | 103,800 |
| 2022/01/21 | 1,056 | 1,064 | 1,024 | 1,045 | -22 | -2.1% | 180,200 |
| 2022/01/20 | 1,054 | 1,083 | 1,049 | 1,067 | +4 | +0.4% | 140,100 |
| 2022/01/19 | 1,075 | 1,080 | 1,055 | 1,063 | -30 | -2.7% | 195,900 |
| 2022/01/18 | 1,130 | 1,143 | 1,086 | 1,093 | -48 | -4.2% | 183,500 |
| 2022/01/17 | 1,123 | 1,165 | 1,121 | 1,141 | +18 | +1.6% | 166,200 |
| 2022/01/14 | 1,111 | 1,128 | 1,092 | 1,123 | +11 | +1% | 150,400 |
| 2022/01/13 | 1,110 | 1,127 | 1,107 | 1,112 | -9 | -0.8% | 97,200 |
| 2022/01/12 | 1,134 | 1,137 | 1,106 | 1,121 | -4 | -0.4% | 125,800 |
| 2022/01/11 | 1,086 | 1,135 | 1,085 | 1,125 | +16 | +1.4% | 263,500 |
| 2022/01/07 | 1,080 | 1,110 | 1,073 | 1,109 | +25 | +2.3% | 189,400 |
| 2022/01/06 | 1,085 | 1,111 | 1,068 | 1,084 | -24 | -2.2% | 248,500 |
| 2022/01/05 | 1,152 | 1,155 | 1,083 | 1,108 | -56 | -4.8% | 336,100 |
| 2022/01/04 | 1,187 | 1,188 | 1,154 | 1,164 | -10 | -0.9% | 157,700 |
| 2021/12/30 | 1,183 | 1,192 | 1,154 | 1,174 | -14 | -1.2% | 258,600 |
| 2021/12/29 | 1,163 | 1,192 | 1,159 | 1,188 | +25 | +2.1% | 285,000 |
| 2021/12/28 | 1,196 | 1,199 | 1,138 | 1,163 | -5 | -0.4% | 409,700 |
| 2021/12/27 | 1,177 | 1,202 | 1,116 | 1,168 | +11 | +1% | 603,500 |
| 2021/12/24 | 1,161 | 1,208 | 1,150 | 1,157 | -87 | -7% | 1,005,800 |
| 2021/12/23 | 1,040 | 1,349 | 1,033 | 1,244 | +195 | +18.6% | 4,825,900 |
| 2021/12/22 | 1,070 | 1,097 | 1,001 | 1,049 | +32 | +3.1% | 1,798,100 |
| 2021/12/21 | 1,017 | 1,017 | 1,017 | 1,017 | +150 | +17.3% | 32,600 |
| 2021/12/20 | 881 | 889 | 864 | 867 | -13 | -1.5% | 137,700 |
851～
900
件表示中 / 3450件
類似銘柄と比較する
現在ご覧いただいている「ラクオリア」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ラクオリア | 54,000円 | +25.1% | - | 0.00% | - | 2.11倍 |
|
ファイザー旧国内研究所が前身。導出消化器薬の海外売上が拡大、収益柱に。低分子創薬に強い |
| 大幸薬品 | 31,800円 | +0.1% | -70.9% | 0.00% | 35.49倍 | 2.01倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。感染管理「クレベリン」事業は再構築中 |
| ステラファーマ | 40,800円 | +4.8% | - | 0.00% | - | 4.33倍 |
|
ステラケミファ系、持分会社に。がん放射線治療用ホウ素医薬品が柱。適応拡大・海外展開注力 |
| Ｃｈｏｒｄｉａ | 18,000円 | - | - | 0.00% | - | 3.83倍 |
|
ＲＮＡ制御ストレスを標的とする低分子抗がん薬を開発中。開発品・研究者は武田にルーツ |
| セルソース | 62,300円 | - | - | 0.80% | 48.41倍 | 2.09倍 |
|
脂肪・血液由来の細胞加工受託など再生医療、変形性ひざ関節症向け軸に不妊治療関連も展開 |
市場注目の銘柄
チャート関連のコラム
